[1]中国糖尿病足细胞与介入治疗技术联盟,中国介入医师分会介入医学与生物工程 技术委员会,国家放射与治疗临床医学研究中心.糖尿病足介入综合诊治临床指南（第六版）[J].介入放射学杂志,2020,29(09):853-866.
　China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot,Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch,National Centre for Clinical Medical Research on Radiation and Treatment. LI Maoquan..Clinical guidelines for integrated diagnosis and treatment of diabetic foot(sixth edition)[J].journal interventional radiology,2020,29(09):853-866.
点击复制

糖尿病足介入综合诊治临床指南（第六版）()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年09
页码:
853-866
栏目:
指南与共识
出版日期:
2020-09-25

文章信息/Info

Title:
Clinical guidelines for integrated diagnosis and treatment of diabetic foot(sixth edition)
作者:
中国糖尿病足细胞与介入治疗技术联盟; 中国介入医师分会介入医学与生物工程 技术委员会; 国家放射与治疗临床医学研究中心
Author(s):
China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot;  Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch;  National Centre for Clinical Medical Research on Radiation and Treatment. LI Maoquan.
Department of Interventional and Vascular Surgery， Affiliated Tenth People’s Hospital of Tongji University， Interventional Vascular Institute of Tongji University， Shanghai 200072， China
关键词:
【关键词】 糖尿病足;  糖尿病;  介入综合诊治;  临床指南
文献标志码:
A
摘要:
【摘要】 糖尿病足是糖尿病最常见并发症之一，具有发病率高、致残率高、致死率高和治愈率低的特点，严重影响国人的身体健康和生活质量，其治疗却一直没有统一的规范方法。中国糖尿病足细胞与介入治疗技术联盟2015制定了糖尿病足介入综合诊治临床指南（第一版），填补了国内糖尿病足治疗规范的空白，对提高我国救治水平起到了重要作用。本次第六版修订借鉴国际最新指南，联盟组织国内多家单位，在第五版基础上，将相关指标和定义进一步完善更新。本指南着重于临床实际应用，从病理基础、疾病诊断、病情评估、治疗方案、术后护理和预后转归等多方面进行探讨和总结，以推动规范我国糖尿病足临床诊治。

参考文献/References:

［1］ Hingorani A， La Muraglia GM， Henke P， et al. The management of diabetic foot： a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine［J］. J Vasc Surg， 2016， 63（2 Suppl）：3S- 21S.
［2］ Conte MS， Bradbury AW， Kolh P， et al. Global vascular guidelines on the management of chronic limb- threatening ischemia［J］. J Vasc Surg， 2019， 69（6 Suppl）：3S.e40- 125S.e40. ［3］ Oakley W， Catterall RC， Martin M. Aetiology and management of lesions of the feet in diabetes. Br Med J， 1956， 2：953- 957.
［4］ Catterall WA， Pedersen PL. Adenosine triphosphatase from rat liver mitochondria.Ⅱ. Interaction with adenosine diphosphate［J］. J Biol Chem， 1972， 247：7969- 7976.
［5］ Kalish J， Hamdan A. Management of diabetic foot problem［J］. J Vasc Surg， 2010， 51：476- 486.
［6］ Selvin E， Marinopoulos S， Berkenblit G， et al. Meta analysis： Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus［J］. Ann Intern Med， 2004，141：421- 431.
［7］ Gershater MA， L?觟ndahl M， Nyberg P， et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers： a cohort study. Diabetologia， 2009， 52：398- 407.
［8］ Apelqvist J. The foot in perspective［J］. Diabetes Metab Res Rev， 2008， 24（Suppl 1）：S110- S115.
［9］ Apelqvist J， Bakker K， Van Houtum WH， et al. International consensus and practical guidelines on the management and the prevention of the diabetic foot. Intational Working Group on the Dabitic Foot［J］. Diabetes Metab Res Rev， 2000，16（Suppl 1）：S84-S 92.
［10］ Jeffcoate WJ， Chipchase SY， Ince P， et al. Assessing the outcome of the management of diabetic foot ulcers using ulcerrelated and person- related measures［J］. Diabetes Care， 2006，29：1784- 1787.
［11］ Clairotte C， Retout S， Potier L， et al. Automated ankle- brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients［J］. Diabetes Care， 2009， 32：1231- 1236.
［12］ Norgren L， Hiatt WR， Dormandy JA， et al. Inter- society consensus for the management of peripheral arterial disease（TASCⅡ）［J］. Eur J Vasc Endovasc Surg， 2007， 33（Suppl 1）：S1- S75.
［13］ European Society of Hypertension- European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension［J］. J Hypertens， 2003， 21：1011- 1053.
［14］ American Diabetes Association. Standards of medical care in diabetes- 2006［J］. Diabetes Care， 2006， 29（Suppl 1）：S4- S42.
［15］ Lepantalo M， Apelqvist J， Setacci C， et al. Chapter V： Diabetic Foot［J］. Eur J Vasc Endovasc Surg， 2011， 42（Suppl 2）：S60- S74.
［16］ Elraiyah T， Tsapas A， Prutsky G， et al. A systematic review and meta- analysis of adjunctive therapies in diabetic foot ulcers［J］. J Vasc Surg， 2016， 63（Suppl 2）：46S.el-2- 58S.el-2.
［17］ Meloni M， Izzo V， Vainieri E， et al. Management of negative pressure wound therapy in the treatment of diabetic foot ulcers［J］. World J Orthop， 2015， 6： 387- 393.
［18］ Shi R， Jin Y， Cao C， et al. Localization of human adipose- derived stem cells and their effect in repair of diabetic foot ulcers in rats［J］. Stem Cell Res Ther， 2016， 7：155.
［19］陈亚冠， 曹烨民， 陈 强， 等. 老年重症糖尿病足坏疽截肢的围手术期治疗分析［J］. 中国骨伤， 2006， 19： 333- 334.
［20］ 关小宏. 糖尿病足治疗新技术进展［J］. 空军医学杂志， 2011， 27： 96- 98.
［21］ 汪 涛， 赵 珺. 糖尿病足坏疽截肢平面的判定［J］. 中国现代普通外科进展， 2014， 17：76- 80.
［22］ Gu YQ. Determination of amputation level in ischaemic lower limbs［J］. ANZ J Surg， 2004， 74：31- 33.
［23］谷涌泉， 张 建， 汪忠镐， 等. 糖尿病性下肢缺血的外科治疗 ［J］. 中华糖尿病杂志， 2004， 12： 328-331.
［24］ Lu C， Zhang X， Zhang D， et al. Short time tripterine treatment enhances endothelial progenitor cell function via heat shock protein 32［J］. J Cell Physiol， 2015， 230：1139- 1147.
［25］ Lu C， Yu X， Zuo K， et al. Tripterine treatment improves endothelial progenitor cell function via integrin- linked kinase［J］.Cell Physiol Biochem， 2015， 37：1089- 1103.
［26］ Zuo K， Li M， Zhang X， et al. MiR- 21 suppresses endothelial progenitor cell proliferation by activating the TGFβ signaling pathway via downregulation of WWP1［J］. Int J Clin Exp Pathol，2015， 8：414- 422.
［27］ Zhang X， Lian W， Lou W， et al. Transcatheter arterial infusion of autologous CD133+ cells for diabetic peripheral artery disease［J］. Stem Cells Int， 2016， 2016：6925357.
［28］ Zhao WN， Xu SQ， Liang JF， et al. Endothelial progenitor cells from human fetal aorta cure diabetic foot in a rat model［J］. Metabolism，2016， 65：1755- 1767.
［29］ Wu Q， Chen B， Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot［J］. Stem Cells Int， 2016， 2016：4612167.
［30］ Hinchliffe RJ， Forsythe RO， Apelqvist J， et al. Guidelines on diagnosis， prognosis， and management of peripheral artery disease in patients with foot ulcers and diabetes（IWGDF 2019 update）［J］. Diabetes Metab Res Rev， 2020， 36：e3276.
［31］ Hinchliffe RJ， Brownrigg JR， Apelqvist J， et al. IWGDF guidance on the diagnosis， prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes［J］. Diabetes Metab Res Rev， 2016， 32（Suppl 1）：37- 44.
［32］ Asadi MR， Torkaman G， Hedayati M， et al. Angiogenic effects of low- intensity cathodal direct current on ischemic diabetic foot ulcers： a randomized controlled trial［J］. Diabetes Res Clin Pract，2017， 127：147- 155.
［33］ 莫 伟，向 华，阳秀春， 等. 股动脉穿刺介入术后制动时间的循证证据研究［J］. 介入放射学杂， 2019， 28：85- 88.
［34］ Chatwin KE， Abbott CA， Reddy PN， et al. A foreign body through the shoe of a person with diabetic peripheral neuropathy alters contralateral biomechanics： captured through innovative plantar pressure technology［J］. Int J Low Extrem Wounds， 2018， 17：125- 129.
［35］ Crisologo PA， Lavery LA. Remote home monitoring to identify and prevent diabetic foot ulceration［J］. Ann Transl Med， 2017，5：430.
［36］ Yi F， Hou W， Zhou C， et al. Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation： meta- analysis of safety and efficacy［J］. J Cardiovasc Pharmacol， 2019， 73：241- 247.
［37］ Wang WZ， Liu DH， Li DJ， et al. Nanofibrous vascular scaffold prepared from miscible polymer blend with heparin/stromal cell- derived factor- 1 alpha for enhancing anticoagulation and endothe- lialization［J］. Colloids Surf， 2019， 181： 963- 972.
［38］ Shi Z， Zhang Y， Liu T， et al. Synthesis of BiOBr/Ag3PO4 hete- rojunctions on carbon- fiber cloth as filter- membrane- shaped photocatalyst for treating the flowing antibiotic wastewater［J］. J Colloid Interface Sci， 2020， 575：183- 193.

相似文献/References:

[1]朱悦琦,赵俊功,李明华,等.经足背－足底或足底－足背动脉环逆行腔内成形术治疗糖尿病踝下动脉闭塞性病变的临床研究[J].介入放射学杂志,2011,(03):185.
　ZHU Yue-qi,ZHAO Jun-gong,LI Ming-hua,et al.Retrograde transdorsal-to-plantar or transplantar-to-dorsal intraluminal re-entry treatment following unsuccessful subintimal angioplasty for below-the-ankle arterial occlusion[J].journal interventional radiology,2011,(09):185.
[2]国际血管联盟中国分会糖尿病足专业委员会.糖尿病足诊治指南[J].介入放射学杂志,2013,(09):705.
　Diabetic Foot Committee GU Yong? quan. Guideline on the diagnosis and treatment of diabetic foot China Branch of the International Union of Angiology[J].journal interventional radiology,2013,(09):705.
[3]王春梅,谷涌泉,李建新,等. 糖尿病足介入治疗围手术期处理[J].介入放射学杂志,2013,(09):780.
　WANG Chun? mei,GU Yong? quan,LI Jian? xin,et al. Perioperative management of interventional therapy for diabetic foot[J].journal interventional radiology,2013,(09):780.
[4]李 菁,王 珏. 糖尿病足的影像学研究进展[J].介入放射学杂志,2014,(05):456.
　LI Jing,WANG Jue.. Advances in imaging research of diabetic foot .[J].journal interventional radiology,2014,(09):456.
[5]李 鑫,王黎洲,李 兴,等.糖尿病患者颈动脉支架植入后认知功能与S-100 B蛋白水平探讨[J].介入放射学杂志,2015,(08):653.
　LI Xin,WANG Li- zhou,LI Xing,et al.Investigation of cognitive function and serum S- 100 B protein level in diabetic patients after receiving carotid artery stent implantation[J].journal interventional radiology,2015,(09):653.
[6]马 旭,李跃华,王建波.糖尿病下肢血管病的血管内治疗进展[J].介入放射学杂志,2015,(11):1011.
　MA Xu,LI Yue- hua,WANG Jian- bo.Recent progress in endovascular treatment for diabetic lower extremity vascular disease[J].journal interventional radiology,2015,(09):1011.
[7]田红岸,余开湖,林凤平,等.自体干细胞介入治疗糖尿病足临床效果观察[J].介入放射学杂志,2016,(12):1040.
　TIAN Hong- an,YU Kai- hu,LIN Feng- ping,et al.PTA combined with transplantation of autologous bone marrow stem cells for diabetic foot： observation of clinical effect[J].journal interventional radiology,2016,(09):1040.
[8]刘光华,俞炬明,范国平,等.肝细胞癌患者伴发糖尿病行肝动脉化疗栓塞术的预后因素分析 [J].介入放射学杂志,2017,(10):926.
　LIU Guanghua,YU Juming,FAN Guoping,et al.Analysis of prognostic factors in patients with hepatocellular carcinoma complicated by diabetes mellitus after transcatheter arterial chemoembolization[J].journal interventional radiology,2017,(09):926.
[9]吕在刚,王琳娜,陈晓辉,等.脑血管病伴糖尿病患者介入治疗后对比剂对肾功能的影响 [J].介入放射学杂志,2018,27(03):277.
　LV Zaigang,WANG Linna,CHEN Xiaohui,et al.Effect of contrast media on renal function in patients with cerebrovascular disease complicated by diabetes mellitus after receiving interventional treatment[J].journal interventional radiology,2018,27(09):277.
[10]崔文军,王 兵,安 乾,等.斑块旋切术治疗糖尿病膝下动脉病变效果分析[J].介入放射学杂志,2019,28(05):476.
　CUI Wenjun,WANG Bing,AN Qian,et al.Directional atherectomy for the treatment of infrapopliteal arterial disease in diabetic patients： analysis of its curative effect[J].journal interventional radiology,2019,28(09):476.
[11]中国糖尿病足细胞与介入治疗技术联盟,中国医师协会介入医师分会介入医学与生物工程技术委员会,国家放射与治疗临床医学研究中心.糖尿病足介入综合诊治临床指南（第九版） [J].介入放射学杂志,2024,33(04):341.
　China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot,Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch,National Centre for Clinical Medical Research on Radiation and Treatment.Clinical guidelines for comprehensive interventional management of the diabetic foot（9th Edition） [J].journal interventional radiology,2024,33(09):341.

备注/Memo

备注/Memo:
（收稿日期：2020- 02- 06）
（本文编辑：边 佶）
更新日期/Last Update: 2020-09-15